RankingsPricing
  1. US-listed companies
  2. ACURA PHARMACEUTICALS, INC
  3. Financials
  4. Net income

ACURA PHARMACEUTICALS, INCACUR

Market cap
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2021-1-27.24%
Dec 31, 2020-1-67.99%
Dec 31, 2019-4-1.77%
Dec 31, 2018-4-32.38%
Dec 31, 2017-6-23.09%
Dec 31, 2016-7+48.09%
Dec 31, 2015-5-62.23%
Dec 31, 2014-13-4.98%
Dec 31, 2013-14+43.78%
Dec 31, 2012-10-193.10%
Dec 31, 201110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)